Axitinib: from preclinical development to future clinical perspectives in renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Axitinib: from preclinical development to future clinical perspectives in renal cell carcinoma

Published:2015-06-03 Issue:8 Volume:10 Page:925-935
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Zakharia Yousef¹,Zakharia Kais²,Rixe Olivier³

Affiliation:

1. 1University of Iowa Division of Hematology/Oncology and Holden Comprehensive Cancer Center, Iowa City, Iowa, USA

2. 2Mayo Clinic College of Medicine - Division of Gastroenterology and Hepatology, Rochester, Minnesota, USA

3. 3University of New Mexico Cancer Center, Division of Hematology/Oncology, Albuquerque, New Mexico, USA

Publisher

Informa Healthcare

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1517/17460441.2015.1045411

Reference47 articles.

1. Cancer statistics, 2014

2. Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma

3. Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

4. Immunotherapy for Renal Cell Cancer

5. Biology and Clinical Development of Vascular Endothelial Growth Factor–Targeted Therapy in Renal Cell Carcinoma

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenesis of Port-Wine Stains: Directions for Future Therapies;International Journal of Molecular Sciences;2022-10-12

2. Discovery of potent thieno[2,3-d]pyrimidine VEGFR-2 inhibitors: Design, synthesis and enzyme inhibitory evaluation supported by molecular dynamics simulations;Bioorganic Chemistry;2021-08

3. Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades;Pharmaceuticals;2021-07-22

4. Novel VEGFR‐2 inhibitors with an N ‐acylhydrazone scaffold;Archiv der Pharmazie;2020-07-15

5. VEGFR-2 inhibitors and apoptosis inducers: synthesis and molecular design of new benzo[g]quinazolin bearing benzenesulfonamide moiety;Journal of Enzyme Inhibition and Medicinal Chemistry;2017-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3